| AGE | Advanced glycation end product |
| AMPK | AMP-activated protein kinase |
| ApoE-/- | Apolipoprotein E knockout |
| CaMKK | Calcium/calmodulin-dependent protein kinase kinase |
| cAMP | Cyclic adenosine monophosphate |
| CCL | Chemokine ligand |
| CREB | cAMP response element-binding protein |
| CVD | Cardiovascular disease |
| DPP | Dipeptidyl peptidase |
| ET | Endothelin |
| GIP | Glucose-dependent insulinotropic polypeptide |
| GIPR | GIP receptor |
| GLP-1 | Glucagon like peptide-1 |
| GLP-1RA | GLP-1 receptor agonist |
| HUV | Human umbilical vein |
| IL | Interleukin |
| LDL | Low density lipoprotein |
| LKB | Liver kinase B |
| LPS | Lipopolysaccharide |
| NO | Nitric oxide |
| NOS | Nitric oxide synthase |
| PAI | Plasminogen activator inhibitor |
| PKA | Protein kinase A |
| PLC | Phospholipase C |
| PTA | Percutaneous transluminal angioplasty |
| SMC | Smooth muscle cell |
| TNF | Tumor necrosis factor |
| VEC | Vascular endothelial cell |
| VSMC | Vascular smooth muscle cell |